Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics, Inc. (FOLD) since 2007 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1178879.
Total stock buying since 2007: $164,927,777.
Total stock sales since 2007: $289,464,081.
Total stock option exercises since 2007: $43,076,426.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 400 | $4,000 | 400 | $3,611 |
| 2024 | 0 | $0 | 399,658 | $5,124,634 | 182,067 | $1,360,541 |
| 2023 | 0 | $0 | 813,767 | $10,307,679 | 457,240 | $2,081,221 |
| 2022 | 0 | $0 | 424,370 | $4,449,738 | 116,155 | $466,726 |
| 2021 | 45,105 | $451,689 | 557,791 | $7,173,882 | 411,757 | $2,127,182 |
| 2020 | 11,000 | $175,512 | 1,681,390 | $24,511,559 | 1,284,060 | $8,873,723 |
| 2019 | 4,945 | $49,796 | 572,269 | $6,783,107 | 547,724 | $2,955,368 |
| 2018 | 1,235,827 | $15,744,014 | 301,765 | $4,590,161 | 201,765 | $1,644,814 |
| 2017 | 1,501,395 | $18,395,032 | 971,072 | $12,606,562 | 913,823 | $11,449,856 |
| 2016 | 592,950 | $3,020,945 | 1,260,420 | $8,649,277 | 156,358 | $50,864 |
| 2015 | 810,000 | $5,440,410 | 1,080,786 | $13,931,432 | 1,273,641 | $11,766,749 |
| 2014 | 6,467,084 | $30,224,665 | 11,682,909 | $62,446,695 | 16,491 | $10,521 |
| 2013 | 1,525,000 | $3,085,000 | 0 | $0 | 0 | $0 |
| 2012 | 9,361,554 | $55,128,673 | 0 | $0 | 49,931 | $31,955 |
| 2011 | 30,000 | $162,800 | 2,250 | $16,875 | 2,250 | $1,435 |
| 2010 | 11,898 | $43,903 | 0 | $0 | 0 | $0 |
| 2009 | 20,000 | $82,600 | 71,908 | $765,927 | 5,924 | $8,466 |
| 2008 | 1,834,162 | $27,685,294 | 677,689 | $127,429,143 | 153,582 | $191,652 |
| 2007 | 461,042 | $5,237,444 | 44,894 | $673,410 | 81,102 | $51,742 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-01 | Quimi Daphne (Chief Financial Officer) | Option Ex | 19,872 | 2.69 | 53,555 |
| 2020-07-01 | Crowley John F (Chairman & CEO) | Sale | 39,655 | 15.48 | 613,859 |
| 2020-07-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.96 | 119,200 |
| 2020-07-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 12,500 | 15.47 | 193,387 |
| 2020-07-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 12,500 | 6.06 | 75,750 |
| 2020-07-01 | Whitman Burke W (Director) | Buy | 1,500 | 15.20 | 22,800 |
| 2020-06-29 | Barth Jay (Chief Medical Officer) | Sale | 30,000 | 15.51 | 465,210 |
| 2020-06-29 | Barth Jay (Chief Medical Officer) | Option Ex | 30,000 | 5.13 | 153,900 |
| 2020-06-19 | Prout Samantha (Principal Accounting Officer) | Sale | 3,366 | 15.00 | 50,490 |
| 2020-06-19 | Prout Samantha (Principal Accounting Officer) | Option Ex | 3,366 | 10.04 | 33,794 |
| 2020-06-17 | Barth Jay (Chief Medical Officer) | Sale | 1,904 | 13.47 | 25,639 |
| 2020-06-16 | Prout Samantha (Principal Accounting Officer) | Sale | 2,932 | 12.95 | 37,957 |
| 2020-06-15 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 10.88 | 217,620 |
| 2020-06-15 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2020-06-02 | Campbell Bradley L (Chief Operating Officer) | Sale | 2,500 | 13.01 | 32,525 |
| 2020-06-02 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 2,500 | 6.06 | 15,149 |
| 2020-06-02 | Whitman Burke W (Director) | Buy | 2,000 | 12.65 | 25,310 |
| 2020-06-01 | Crowley John F (Chairman & CEO) | Sale | 9,755 | 12.65 | 123,449 |
| 2020-06-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 17,502 | 12.65 | 221,487 |
| 2020-06-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,000 | 6.06 | 60,599 |
| 2020-06-01 | Raab Michael (Director) | Sale | 5,000 | 12.65 | 63,259 |
| 2020-06-01 | Raab Michael (Director) | Option Ex | 5,000 | 2.81 | 14,050 |
| 2020-05-26 | Campbell Bradley L (Chief Operating Officer) | Sale | 2,500 | 13.01 | 32,525 |
| 2020-05-26 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 2,500 | 6.06 | 15,149 |
| 2020-05-15 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 11.44 | 228,800 |
| 2020-05-15 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2020-05-01 | Crowley John F (Chairman & CEO) | Sale | 9,755 | 11.32 | 110,465 |
| 2020-05-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 17,503 | 11.33 | 198,238 |
| 2020-05-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 10,000 | 6.06 | 60,599 |
| 2020-04-17 | Mcglynn Margaret G (Director) | Sale | 10,000 | 11.00 | 110,000 |
| 2020-04-17 | Mcglynn Margaret G (Director) | Option Ex | 10,000 | 2.81 | 28,100 |
| 2020-04-15 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 9.92 | 198,420 |
| 2020-04-15 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2020-04-07 | Campbell Bradley L (Chief Operating Officer) | Sale | 2,500 | 10.12 | 25,299 |
| 2020-04-07 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 2,500 | 6.06 | 15,149 |
| 2020-04-01 | Crowley John F (Chairman & CEO) | Sale | 9,755 | 9.08 | 88,604 |
| 2020-04-01 | Campbell Bradley L (Chief Operating Officer) | Sale | 15,003 | 9.09 | 136,317 |
| 2020-04-01 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 7,500 | 6.06 | 45,450 |
| 2020-03-20 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 9.00 | 180,000 |
| 2020-03-20 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2020-03-05 | Campbell Bradley L (Chief Operating Officer) | Sale | 2,500 | 10.01 | 25,025 |
| 2020-03-05 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 2,500 | 5.96 | 14,900 |
| 2020-03-02 | Crowley John F (Chairman & CEO) | Sale | 9,755 | 9.10 | 88,741 |
| 2020-03-02 | Campbell Bradley L (Chief Operating Officer) | Sale | 15,003 | 9.10 | 136,452 |
| 2020-03-02 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 7,500 | 5.96 | 44,700 |
| 2020-02-18 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 10.83 | 216,680 |
| 2020-02-18 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2020-02-12 | Do Hung (Chief Science Officer) | Sale | 63,356 | 11.01 | 697,359 |
| 2020-02-12 | Do Hung (Chief Science Officer) | Option Ex | 53,100 | 6.61 | 351,150 |
| 2020-02-05 | Campbell Bradley L (Chief Operating Officer) | Sale | 2,500 | 10.01 | 25,025 |
| 2020-02-05 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 2,500 | 5.96 | 14,900 |
| 2020-02-03 | Crowley John F (Chairman & CEO) | Sale | 9,754 | 8.91 | 86,878 |
| 2020-02-03 | Campbell Bradley L (Chief Operating Officer) | Sale | 15,003 | 8.91 | 133,631 |
| 2020-02-03 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 7,500 | 5.96 | 44,700 |
| 2020-01-15 | Rosenberg Ellen (Chief Legal Officer) | Sale | 22,100 | 10.35 | 228,646 |
| 2020-01-15 | Barth Jay (Chief Medical Officer) | Sale | 20,720 | 10.35 | 214,369 |
| 2020-01-15 | Crowley John F (Chairman & CEO) | Sale | 100,000 | 10.35 | 1,034,800 |
| 2020-01-15 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2020-01-15 | Campbell Bradley L (Chief Operating Officer) | Sale | 5,064 | 10.35 | 52,387 |
| 2020-01-09 | Quimi Daphne (Chief Financial Officer) | Sale | 15,000 | 9.93 | 148,950 |
| 2020-01-09 | Quimi Daphne (Chief Financial Officer) | Option Ex | 11,022 | 3.45 | 38,025 |
| 2020-01-09 | Campbell Bradley L (Chief Operating Officer) | Sale | 2,500 | 10.01 | 25,025 |
| 2020-01-09 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 2,500 | 5.96 | 14,900 |
| 2020-01-09 | Mcglynn Margaret G (Director) | Sale | 20,000 | 10.00 | 200,000 |
| 2020-01-09 | Mcglynn Margaret G (Director) | Option Ex | 20,000 | 3.32 | 66,400 |
| 2020-01-07 | Barth Jay (Chief Medical Officer) | Sale | 9,938 | 9.36 | 92,979 |
| 2020-01-06 | Barth Jay (Chief Medical Officer) | Sale | 6,836 | 9.28 | 63,417 |
| 2020-01-02 | Rosenberg Ellen (Chief Legal Officer) | Sale | 10,448 | 9.56 | 99,882 |
| 2020-01-02 | Barth Jay (Chief Medical Officer) | Sale | 9,753 | 9.55 | 93,170 |
| 2020-01-02 | Campbell Bradley L (Chief Operating Officer) | Sale | 22,127 | 9.58 | 212,043 |
| 2020-01-02 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 7,500 | 5.96 | 44,700 |
| 2019-12-16 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 9.55 | 191,020 |
| 2019-12-16 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2019-12-02 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 10.38 | 207,620 |
| 2019-12-02 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 3.82 | 76,400 |
| 2019-11-15 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 9.52 | 190,400 |
| 2019-11-15 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2019-11-08 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 9.02 | 180,420 |
| 2019-11-08 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 5.13 | 102,600 |
| 2019-10-11 | Crowley John F (Chairman & CEO) | Sale | 14,500 | 8.01 | 116,072 |
| 2019-09-11 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 10.05 | 201,040 |
| 2019-09-11 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 3.82 | 76,400 |
| 2019-08-23 | Whitman Burke W (Director) | Buy | 4,945 | 10.07 | 49,796 |
| 2019-08-01 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 12.54 | 250,740 |
| 2019-08-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 3.82 | 76,400 |
| 2019-07-01 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 12.47 | 249,460 |
| 2019-07-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 3.82 | 76,400 |
| 2019-06-03 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 11.15 | 223,080 |
| 2019-06-03 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 3.82 | 76,400 |
| 2019-06-03 | Raab Michael (Director) | Sale | 5,000 | 11.15 | 55,775 |
| 2019-06-03 | Raab Michael (Director) | Option Ex | 5,000 | 7.15 | 35,750 |
| 2019-05-01 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 13.51 | 270,160 |
| 2019-05-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 3.82 | 76,400 |
| 2019-04-05 | Barth Jay (Chief Medical Officer) | Sale | 50,000 | 14.20 | 710,200 |
| 2019-04-05 | Barth Jay (Chief Medical Officer) | Option Ex | 50,000 | 2.29 | 114,500 |
| 2019-04-01 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 13.63 | 272,620 |
| 2019-04-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 3.50 | 70,100 |
| 2019-03-01 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 13.38 | 267,580 |
| 2019-03-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 4.49 | 89,740 |
| 2019-02-25 | Barth Jay (Chief Medical Officer) | Sale | 70,000 | 12.52 | 876,120 |
| 2019-02-25 | Barth Jay (Chief Medical Officer) | Option Ex | 70,000 | 2.62 | 183,050 |
| 2019-02-01 | Crowley John F (Chairman & CEO) | Sale | 20,000 | 12.12 | 242,320 |
| 2019-02-01 | Crowley John F (Chairman & CEO) | Option Ex | 20,000 | 3.82 | 76,400 |
| 2019-01-22 | Campbell Bradley L (Chief Operating Officer) | Sale | 36,000 | 11.81 | 425,124 |
| 2019-01-22 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 36,000 | 10.36 | 372,960 |
| 2019-01-16 | Do Hung (Chief Science Officer) | Sale | 36,669 | 12.05 | 441,861 |
| 2019-01-16 | Do Hung (Chief Science Officer) | Option Ex | 35,024 | 4.04 | 141,321 |
| 2019-01-15 | Do Hung (Chief Science Officer) | Sale | 16,600 | 12.00 | 199,200 |
| 2019-01-15 | Do Hung (Chief Science Officer) | Option Ex | 8,200 | 4.04 | 33,087 |
| 2019-01-15 | Crowley John F (Chairman & CEO) | Sale | 103,500 | 11.71 | 1,212,295 |
| 2019-01-15 | Crowley John F (Chairman & CEO) | Option Ex | 103,500 | 10.36 | 1,072,260 |
| 2018-10-15 | Baird William D Iii (Chief Financial Officer) | Sale | 10,000 | 12.23 | 122,280 |
| 2018-10-15 | Baird William D Iii (Chief Financial Officer) | Option Ex | 10,000 | 2.45 | 24,500 |
| 2018-10-03 | Edelman Joseph (10% Owner) | Buy | 30,000 | 12.69 | 380,700 |
| 2018-09-24 | Edelman Joseph (10% Owner) | Buy | 20,000 | 12.45 | 249,000 |
| 2018-09-21 | Edelman Joseph (10% Owner) | Buy | 50,000 | 12.53 | 626,500 |
| 2018-09-13 | Edelman Joseph (10% Owner) | Buy | 100,000 | 11.74 | 1,174,000 |
| 2018-09-12 | Edelman Joseph (10% Owner) | Buy | 500,000 | 12.00 | 6,001,500 |
| 2018-07-02 | Andrews Kurt J. (SVP, Human Resources) | Sale | 5,000 | 15.63 | 78,165 |
| 2018-07-02 | Andrews Kurt J. (SVP, Human Resources) | Option Ex | 5,000 | 6.13 | 30,650 |
| 2018-07-02 | Baird William D Iii (Chief Financial Officer) | Sale | 10,000 | 15.63 | 156,290 |
| 2018-07-02 | Baird William D Iii (Chief Financial Officer) | Option Ex | 10,000 | 2.45 | 24,500 |
| 2018-06-01 | Do Hung (Chief Science Officer) | Sale | 25,000 | 16.72 | 418,000 |
| 2018-05-16 | Do Hung (Chief Science Officer) | Sale | 25,000 | 15.00 | 375,000 |
| 2018-05-16 | Mcglynn Margaret G (Director) | Sale | 10,000 | 16.00 | 160,000 |
| 2018-05-16 | Mcglynn Margaret G (Director) | Option Ex | 10,000 | 3.32 | 33,200 |
| 2018-05-14 | Barth Jay (Chief Medical Officer) | Sale | 5,000 | 14.04 | 70,225 |
| 2018-05-14 | Barth Jay (Chief Medical Officer) | Option Ex | 5,000 | 2.29 | 11,450 |
| 2018-04-17 | Do Hung (Chief Science Officer) | Sale | 50,000 | 15.00 | 750,000 |
| 2018-04-16 | Raab Michael (Director) | Sale | 5,000 | 14.41 | 72,060 |
| 2018-04-16 | Raab Michael (Director) | Option Ex | 5,000 | 10.53 | 52,650 |
| 2018-04-12 | Barth Jay (Chief Medical Officer) | Sale | 5,000 | 14.72 | 73,600 |
| 2018-04-12 | Barth Jay (Chief Medical Officer) | Option Ex | 5,000 | 2.29 | 11,450 |
| 2018-04-02 | Andrews Kurt J. (SVP, Human Resources) | Sale | 5,000 | 14.27 | 71,345 |
| 2018-04-02 | Andrews Kurt J. (SVP, Human Resources) | Option Ex | 5,000 | 6.13 | 30,650 |
| 2018-04-02 | Baird William D Iii (Chief Financial Officer) | Sale | 10,000 | 14.27 | 142,650 |
| 2018-04-02 | Baird William D Iii (Chief Financial Officer) | Option Ex | 10,000 | 2.45 | 24,500 |
| 2018-03-12 | Barth Jay (Chief Medical Officer) | Sale | 5,000 | 15.05 | 75,255 |
| 2018-03-12 | Barth Jay (Chief Medical Officer) | Option Ex | 5,000 | 2.29 | 11,450 |
| 2018-03-09 | Quimi Daphne (SVP, Finance) | Sale | 8,750 | 15.00 | 131,250 |
| 2018-03-09 | Quimi Daphne (SVP, Finance) | Option Ex | 8,750 | 5.96 | 52,150 |
| 2018-03-05 | Edelman Joseph (10% Owner) | Buy | 335,827 | 13.56 | 4,553,814 |
| 2018-03-02 | Edelman Joseph (10% Owner) | Buy | 100,000 | 13.89 | 1,389,500 |
| 2018-03-01 | Quimi Daphne (SVP, Finance) | Sale | 8,149 | 14.05 | 114,534 |
| 2018-03-01 | Quimi Daphne (SVP, Finance) | Option Ex | 8,149 | 4.16 | 33,899 |
| 2018-03-01 | Edelman Joseph (10% Owner) | Buy | 100,000 | 13.69 | 1,369,000 |
| 2018-01-23 | Barth Jay (Chief Medical Officer) | Sale | 20,000 | 16.80 | 336,000 |
| 2018-01-23 | Barth Jay (Chief Medical Officer) | Option Ex | 20,000 | 2.29 | 45,800 |
| 2018-01-22 | Campbell Bradley L (Chief Operating Officer) | Sale | 32,500 | 15.92 | 517,367 |
| 2018-01-22 | Campbell Bradley L (Chief Operating Officer) | Option Ex | 32,500 | 10.21 | 331,825 |
Insider trading activities including stock purchases, stock sales, and option exercises of FOLD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amicus Therapeutics, Inc. (symbol FOLD, CIK number 1178879) see the Securities and Exchange Commission (SEC) website.